-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.INR↓
Mitarbeiter
4.639
Gland Pharma Limited outperformed den DAX um +117 % vom 20.11.2020 bis 23.08.2021
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von
Dir gefallen die Informationen zu Gland Pharma Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Gland Pharma Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Gland Pharma Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Gland Pharma Limited?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
30 News & Informationen zur Gland Pharma Limited Aktie
Trade setup for Tuesday: Top 15 things to know before Opening Bell
Nagaraj Shetti of HDFC Securities feels the short term trend of Nifty is choppy and similar movement could be expected for the next session.
Gland Consolidated June 2021 Net Sales at Rs 1,153.90 crore, up 30.5% Y-o-Y
Gland Pharma shares rally over 9%; at 52-week high after Q1 earnings
Read more about Gland Pharma shares rally over 9%; at 52-week high after Q1 earnings on Business Standard. Shares of Gland Pharma on Thursday jumped over 9 per cent after the company reported an 11.83 per cent increase in its consolidated net profit for the quarter ended June 30, 2021.
Market Wrap Podcast, July 22: Here's all that happened in the markets today
Read more about Market Wrap Podcast, July 22: Here's all that happened in the markets today on Business Standard. Tech Mahindra, Bajaj Finance, Bharti Airtel and Bajaj Finserv were the top Sensex gainers. On the other hand, HUL, Asian Paints, Bajaj Auto and M&M were the four losers
Gland Pharma share price at record high, zooms 177% from IPO price in 8 months; what’s fueling the up move?
Gland Pharma share price surged over 9 per cent to an all-time high of Rs 4,148.85 apiece on BSE in intraday deals, after the company announced its April-June quarter earnings of FY22.
Gland Pharma share price at record high, zooms 177% from IPO price in 8 months; what’s fueling the up move?
Gland Pharma share price surged over 9 per cent to an all-time high of Rs 4,148.85 apiece on BSE in intraday deals, after the company announced its April-June quarter earnings of FY22.
Gland Pharma shares rally nearly 8%; at 52-week high after Q1 earnings
Read more about Gland Pharma shares rally nearly 8%; at 52-week high after Q1 earnings on Business Standard. Shares of Gland Pharma on Thursday jumped nearly 8 per cent after the company reported an 11.83 per cent increase in its consolidated net profit for the quarter ended June 30, 2021
Gland Standalone June 2021 Net Sales at Rs 1,153.90 crore, up 30.5% Y-o-Y
Gland Pharma shares rally nearly 8%; at 52-week high after Q1 earnings
Drug firm Gland Pharma on Wednesday reported an 11.83 per cent increase in its consolidated net profit to Rs 350.7 crore for the quarter ended June 30, 2021, on account of robust sales in all markets. The company had posted a net profit of Rs 313.6 crore for the corresponding period of the previous fiscal, Gland Pharma said in a regulatory filing.
Gland Pharma rallies 8% on strong revenue growth in June quarter
Read more about Gland Pharma rallies 8% on strong revenue growth in June quarter on Business Standard. Gland Pharma said the growth in revenue was contributed from a mix of launch of new products and volume growth in existing products
Gland Pharma: New product successes in FY22 key to future opportunities
While the US market is still expected to clock 18-20 per cent growth for Gland Pharma in FY22, the company’s foray into non-US markets would accelerate growth in the medium term
Gland Pharma on track to start production of Sputnik V jabs by November
Technology transfer of the drug substance is under way to its dedicated unit at Pashamylaram near Hyderabad, which is ready for commercial production.
Gland Pharma share price at 52-week high on robust June quarter numbers
Gland Pharma has reported a consolidated profit of Rs 350.65 crore in the June quarter against Rs 313.59 crore in the year-ago period.
Stock Markets Live: Sensex, Nifty Open Higher; IDFC Surges After Large Trade
Bajaj Finserv, Ceat, Jubilant Foodworks, Havells, Gland Pharma, ICICI Securities may react as the companies reported quarterly results after the market closed Tuesday.
Bajaj Auto, Hindustan Unilever, UltraTech, Hindustan Zinc are among the companies scheduled to report earnings Thursday. Bajaj Auto among companies holding their annual shareholders’ meeting.
Foreign investors sold net Rs 2,280 crore of stocks on July 19, according to NSDL website.
Buzzing Stocks: HUL, Bajaj Finance, Indiabulls Housing Finance and other stocks in news today
Stocks In the News: Check out the companies making the biggest headlines before the opening bell.
Trade setup for Thursday: Top 15 things to know before Opening Bell
Rajesh Palviya of Axis Securities feels on the downside, any violation of an intraday support zone of 15,580 levels may cause profit booking towards 15,500-15,400 levels.
Gland Pharma Q1FY22 profit rises 12% on new launches, COVID drugs Remdesivir and Enoxaparin
Revenue from operations rose 31 percent YoY to Rs 1,153.9 crore in Q1FY22 versus Rs 884.2 crore in Q1FY21.
Expect commercial supplies of Sputnik vaccine from Indian manufacturers by September: RDIF
COVID-19 vaccine | Serum Institute inks pact with RDIF to make Sputnik V, to begin first batch production in September
Serum Institute and RDIF plan to produce over 300 million doses of the Sputnik V vaccine in India per year.
Taking Stock: Market falls nearly 1%, bank, pharma and metal stocks worst hit
On the BSE, except power, all other sectoral indices ended in the red, with metal, auto and bank indices down 1-2.4 percent.
Taking Stock: Sensex, Nifty end at record close; metals outshine
BSE midcap and smallcap indices ended in the green.
“Buy These 3 Stocks,” Says Broking Firm Sharekhan For Good Returns
One of India’s top brokerage houses, Sharekhan has placed a “buy” on a number of stocks including Finolex Cables, Trent and Gland Pharma. Here are some of the reasons why the firm sees an upside potential in these stocks, with returns of as high as 20% in some of these shares.
After The Bell: Sensex squanders gains after hitting record high, what should investors do on Wednesday?
The Nifty closed above 15,800, which is a positive sign, but for the bulls to regain control, a close above 15,915 is required to take the index towards 16,000, say experts.
Taking Stock: Sensex ends with marginal losses after hitting all-time high; banks outperform
BSE midcap index ended marginally higher, while smallcap index fell 0.26 percent.
Pandemic-period these 11 IPOs turn multibaggers since listing, do you own any?
Why Sputnik V vaccine rollout may not hit full capacity until August-September
Imports of the vaccine from Russia are delayed because of heavy orders from several countries and a likely diversion of supplies for local inoculation drives amid a spike in infections caused by the Delta variant of the coronavirus
Taking Stock: Market snaps 4-day losing streak; smallcaps outperform, metals drag
Gland Pharma, Divis Labs, ICICI Bank, Reliance Industries and Coal India were among the top gainers on the Nifty. Top losers were Tata Steel, Britannia Industries, JSW Steel, Power Grid Corp and Hindalco.
Stock Mantra | This pharma stock that has doubled since November may rally 20% in next 3-6 months
Since February, the stock has been in a steady uptrend, forming higher highs and higher lows on the daily chart. A month ago, the stock hit a high of Rs 3,515 which was followed by a sideways-to-negative price correction, say experts
Trade setup for Wednesday: Top 15 things to know before Opening Bell
Rajesh Palviya of Axis Securities feels any sustainable move above 15,800 levels may cause momentum towards 15,900-15,950 levels.
Best Focused Equity Funds For Aggressive Long Term Investors By ICICI Direct
Focused category of equity mutual funds is certainly not for the novice mutual fund investor but typically should be targeted at by a discerning investor with a considerable risk appetite. Also, typically this set of equity funds for higher return enough to beat inflation as well as other fixed instruments should be pocketed only by those investors who have a longer term horizon of say 7-10 years.